Get the Stockscreener App
0.2438
0.49%
-0.0012
Pomdoctor Ltd Adr stock is traded at $0.2438, with a volume of 29,989.
It is down -0.49% in the last 24 hours and up +5.72% over the past month.
Pomdoctor Ltd is an online medical services platform for chronic diseases in China. With a focus on chronic disease management and pharmaceutical services, its business model forms a one-stop platform for medical services, which organically connects patients to doctors and pharmaceutical products. Its experience in tackling chronic diseases can be traced back to the launch of its platform on mobile devices. The company operates in two segments: Internet hospital, and Pharmaceutical supply chain. The majority of revenue is derived from the Pharmaceutical supply chain segment.
See More
Previous Close:
$0.245
Open:
$0.232
24h Volume:
29,989
Relative Volume:
0.01
Market Cap:
$29.06M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+0.25%
1M Performance:
+5.72%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$0.232
$0.2499
1-Week Range:
$0.225
$0.2717
52-Week Range:
$0.193
$6.43
Pomdoctor Ltd Adr Stock (POM) Company Profile
Name
Pomdoctor Ltd Adr
Sector
Industry
Phone
-
Address
-
Compare POM vs HITI, PETS, RDGT, WGRX
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
POM
Pomdoctor Ltd Adr
|
0.2438 | 29.20M | 0 | 0 | 0 | 0.00 |
|
HITI
High Tide Inc
|
2.47 | 219.60M | 376.07M | -22.41M | 18.73M | -0.298 |
|
PETS
Petmed Express Inc
|
2.74 | 58.42M | 270.52M | -6.08M | 17.42M | -0.2944 |
|
RDGT
Ridgetech Inc
|
1.6889 | 31.48M | 119.97M | -1.45M | 632.50K | -0.9847 |
|
WGRX
Wellgistics Health Inc
|
0.2125 | 22.42M | 28.99M | -39.20M | -3.34M | 0.00 |
Pomdoctor Ltd Adr Stock (POM) Latest News
UPCOMING DEADLINE: Pomdoctor Limited (POM) Securities Fraud Class Action – April 13, 2026 Lead Plaintiff Deadline - ChartMill
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in PomDoctor Ltd. of Class Action Lawsuit and Upcoming Deadlines – POM - ChartMill
POM Investors Have Opportunity to Lead PomDoctor Ltd. Securities Fraud Lawsuit - Barchart.com
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages PomDoctor Ltd. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
POM CLASS ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Pomdoctor (POM) Investors of Securities Class Action Deadline on April 6, 2026 - ChartMill
POM Investors with Large Losses Should Contact Robbins LLP for Information About the POMDoctor Ltd. Securities Class Action Lawsuit - Barchart.com
Shareholders who lost money in American Depositary Receipts of PomDoctor, Ltd. (NASDAQ: POM) Should Contact Wolf Haldenstein Immediately - ChartMill
Shareholders who lost money in American Depositary Receipts - GlobeNewswire
Bronstein, Gewirtz & Grossman LLC Urges PomDoctor, Ltd. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire Inc.
ROSEN, A HIGHLY RANKED LAW FIRM, Encourages PomDoctor Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
Scott+Scott Attorneys at Law LLP Files Securities Class Action Against PomDoctor, Ltd. (NASDAQ: POM) - ChartMill
POM SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Pomdoctor (POM) Investors of Securities Class Action Deadline on April 13, 2026 - Sahm
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages PomDoctor Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
POM INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Pomdoctor (POM) Investors of Securities Class Action Deadline on April 6, 2026 - ChartMill
ROSEN, LEADING INVESTOR COUNSEL, Encourages PomDoctor Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
POM SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Reminds Pomdoctor (POM) Investors of Securities Class Action Deadline on April 13, 2026 - ChartMill
POM SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Pomdoctor (POM) Investors of Securities Class Action Deadline on April 6, 2026 - Sahm
POM Stockholder Alert: Robbins LLP Reminds Investors of the Class Action Against POMDoctor Ltd. - Barchart.com
Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the POMDoctor Ltd. Securities Class Action Lawsuit - ChartMill
Rosen Law Firm Urges PomDoctor Ltd. (NASDAQ: POM) Stockholders to Contact the Firm for Information About Their Rights - ChartMill
Pomdoctor Deepens Medical Insurance Integration to Expand Online Chronic-Care Reach Across Major Chinese Cities - TipRanks
POM SHAREHOLDER ACTION: Faruqi & Faruqi, LLP Reminds Pomdoctor (POM) Investors of Securities Class Action Deadline on April 6, 2026 - Barchart.com
Pomdoctor Receives Nasdaq Deficiency Notice Over Minimum Bid Price - TipRanks
Pomdoctor expands online hospital business through pharma partnerships By Investing.com - Investing.com India
Pomdoctor Deepens Pharma Partnerships to Drive Internet Hospital Expansion in China - TipRanks
United States shares higher at close of trade; Dow Jones Industrial Average up 1.05% - Investing.com India
U.S. shares higher at close of trade; Dow Jones Industrial Average up 1.05% - Investing.com UK
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 1.05% - Investing.com
Pomdoctor (POM) Losses Persist as Price-to-Sales Premium Tests Bullish Scaling Narrative - Sahm
Pomdoctor Limited Reports Strong Revenue Growth Amidst Challenging Conditions - TipRanks
Legence, Cidara Therapeutics, Avadel Pharmaceuticals, Omeros And Other Big Stocks Moving Higher On Friday - Benzinga
Citi (NYSE: C) extends Token Services in Dublin with Euro transfers, 24/7 liquidity - Stock Titan
Citi (NYSE: C) lowers base lending rate to 7.00%, effective Oct 30 at Citibank, N.A. - Stock Titan
Diluted shares outstanding of PomDoctor Ltd. Unsponsored ADR – BOATS:POM - TradingView
Citi Appointed as Depositary Bank for POMDOCTOR LIMITED’s ADR Program - The AI Journal
Citigroup (NYSE:C) Stock Quote - FinancialContent
Free cash flow per share of PomDoctor Ltd. Unsponsored ADR – NASDAQ:POM - TradingView
Citigroup Reports Third Quarter 2025 Results - Business Wire
Q3 2025 Results: Citigroup Reports Results; Webcast & Conference Call at 11 a.m. ET Today - Stock Titan
Earnings calendar for: - Yahoo
$0.60 Quarterly Dividend: Citigroup to Pay Nov 26; Multiple Preferred Series Payments Announced - Stock Titan
Debt to assets ratio of PomDoctor Ltd. Unsponsored ADR – BOATS:POM - TradingView
Gross margin % of PomDoctor Ltd. Unsponsored ADR – BOATS:POM - TradingView
PomDoctor Ltd. Unsponsored ADR Balance Sheet – BOATS:POM - TradingView
Operating margin % of PomDoctor Ltd. Unsponsored ADR – BOATS:POM - TradingView
Diluted earnings per share (Diluted EPS) of PomDoctor Ltd. Unsponsored ADR – BOATS:POM - TradingView
Pomdoctor Ltd Adr Stock (POM) Financials Data
There is no financial data for Pomdoctor Ltd Adr (POM). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
1.88%
1.52%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):